News from CNBC Business

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Tariffs Ceo Investors Stock Earnings Shares Stocks China Eqs Nasdaq Cet Investment Markets Wall Street Tesla Trade Nvidia Revenue Inflation Stock Market Securities Economy Class Action Bitcoin Us Company Sales Apple Trade War Prices Sp 500 Federal Reserve Crypto Ipo Pvr Interest Rates Companies Guidance Warren Buffett Amazon Elon Musk Shareholders Berkshire Hathaway Federal Securities Laws Walmart Trading Investor German Securities Trading Act Gop Voting Rights Cpi Homes Market Value Class B Restaurant Brands International Household Items Capex Jato Dynamics Bac Gross Orders

Filter by:

Rsv × U.S. × CNBC Business ×

CNBC Business • Jun 09, 2025

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

Merck’s newly authorized RSV vaccine for infants is expected to impact the market by challenging established treatments, potentially influencing sales and market share among leadin...

Read Full Article →